PPMI Pathology Core Tatiana Foroud & Tom Montine.

Slides:



Advertisements
Similar presentations
EARLY CHILDHOOD Early Childhood Whats new? All early childhood evaluations will be completed at the local school. This includes Child.
Advertisements

1 10 pt 15 pt 20 pt 25 pt 5 pt 10 pt 15 pt 20 pt 25 pt 5 pt 10 pt 15 pt 20 pt 25 pt 5 pt 10 pt 15 pt 20 pt 25 pt 5 pt 10 pt 15 pt 20 pt 25 pt 5 pt Transition.
Alzheimer’s Disease Neuroimaging Initiative Neuropathology Core John C. Morris, MD Nigel J. Cairns, PhD, FRCPath Erin Householder, MS.
Results All neuropathologies were associated with clinical dementia when controlling for cortical plaques and tangles except Hirano bodies, GVD and brainstem.
Minnesota Assessment System Update Jennifer Dugan “Leading for educational excellence and equity. Every day for every one.”
Alzheimer’s Disease Neuroimaging Initiative Neuropathology Core John C. Morris, MD Nigel J. Cairns, PhD, FRCPath Erin Franklin, MS Presented by: Beau Ances,
Scheduling. Operation Protocol Send an application form to patients Receive the returned application form from patients Check doctor’s schedule Check.
T16 Phase I studies – Phase I units and you, a Phase I unit’s expectation – A Day in the Life of a Phase I Study Coordinator Jeffery Wong, Clinical Research.
AAV2-NRTN (CERE-120) In Parkinson’s Disease: Phase 2 Trial Results and Path Forward Joao Siffert, MD Chief Medical Officer Ceregene, Inc. San Diego, CA.
Neurodevelopmental Disorders Research Center Subject Registry Core A Brief Overview 6/28/2007 University of North Carolina Neurodevelopmental Disorders.
RESIDENT PROJECTS ROBERT LEONHARD QUALITY IMPROVEMENT MANAGER.
Ed Palmisano 06/2005 Evaluation Procedures An Introduction for New School Psychologists and Members of the M- Team.
Evaluation of the Indiana ECCS Initiative. State Context Previous Early Childhood System Initiatives –Step Ahead –Building Bright Beginnings SPRANS Grant.
ISCO Introductions Todd Thorpe – Central Region VP Amy Valentine – ISCO Executive Director, to start 9/9 Pam Decker – ISCO Student Support Coordinator.
Extraordinary and Medically Complex Exemptions for Testing.
April 17, 2012 Expanded Success Initiative Request for Listing Webinar for Approved Organizations.
Nautochia Webb October 28, 2015 U.S. Department of Education Unusual Enrollment History NYSFAAA Annual Conference.
LCG Service Challenges SC2 Goals Jamie Shiers, CERN-IT-GD 24 February 2005.
Kimiko Domoto-Reilly, MD Cognitive / Behavioral Neurology Fellow Massachusetts General Hospital & Brigham and Women’s Hospital.
NCRAD Update Tatiana Foroud, Ph.D. Indiana University.
Apolipoprotein E and Gray Matter Loss in Mild Cognitive Impairment and Alzheimer’s Disease Spampinato MV, Goldsberry G, Mintzer J, Rumboldt Z Medical University.
CPC #7: Pathology Barbara J. Crain, MD, PhD February 25, 2009.
Brain Donation and the BRAIN BANK for AUTISM & Related Developmental Research Dr Jenny Longmore PhD Director of Research and Programmes, Europe Autism.
[Presentation location] [Presentation date] (Confirm ABT logo) Building Bridges and Bonds (B3): An introduction.
0 End of Year Arrangements Training Presentation for Access Practitioners.
Psychology Subject Pool Department of Psychology Syracuse University.
Rare Diseases Clinical Research Network Data Management and Coordinating Center (RDCRN DMCC) Rosalie Holland LDN Investigator Meeting at WORLDSymposium.
Laura Baker, PhD Internal Medicine, Neurology, & Public Health Sciences Wake Forest School of Medicine Winston-Salem, NC USA.
Global Youth Tobacco Survey (GYTS): Overview
IMPAACT 2010 Protocol Specifications for Recruitment, Screening, and Enrollment No updates.
Rosa Maria Moresco University of Milan Bicocca
Psychology Subject Pool
The DEPression in Visual Impairment Trial:
Dementia: from molecules to minds
The Carroll A. Campbell, Jr. Neuropathology Laboratory (Brain Bank)
The 100,000 Genomes Project and the West of England Genomic Medicine Centre Brief update and overview provided by Catherine Carpenter-Clawson, Programme.
Clinicopathologic Conference (CPC) 02/05/16
The clinical, neuroanatomical, and neuropathologic phenotype of TBK1-associated frontotemporal dementia: A longitudinal case report  Carolin A.M. Koriath,
Specification details:
65 year-old female with Alzheimer’s disease
Wearables and Digital Sensor Technology
Future State Business Process Discovery & Design Recap
IDEAS Study. IDEAS Study IDEAS Research Team Study Overview.
PPMI Beyond 2018.
Participation in clinical trials
Amyloid Imaging for Alzheimer's Disease in Practice
Paraprofessional evaluation
Purchase Order for Services
Repositories Lunch Meeting, Day 1
Reisa Sperling, Elizabeth Mormino, Keith Johnson  Neuron 
PPMI – GOALS 2019 Ken Marek PPMI Annual Meeting May 3, 2018
ExCEL After School Behavior Matrix
Example of A* A (4,0) 4 OPEN: (A4) CLOSED: ().
2018 SMU Staff Performance Review Training
Update on the TEA Sped corrective action plan
Progress Seminar 권순빈.
Neuropathology of epilepsy: epilepsy-related deaths and SUDEP
A nonhuman primate model of early Alzheimer's disease pathologic change: Implications for disease pathogenesis  Caitlin S. Latimer, Carol A. Shively,
MRI scans show coronal sections of the brain and right hippocampus at baseline, 9 months, 2 years (when he was diagnosed with mild cognitive impairment)
Purchase Order for Services
ADNI 3 UPDATE MICHAEL WEINER.
Executive Project Kickoff
Project Kick-off <Customer Name> <Project Name>
Agenda for Overview SBCUSD Commission-approved Programs
Research Overview PowerTrials and Related Research Processes
A nonhuman primate model of early Alzheimer's disease pathologic change: Implications for disease pathogenesis  Caitlin S. Latimer, Carol A. Shively,
Detecting and Diagnosing Alzheimer’s Disease
Contact center INNOVATION
December Count Data Entry Training
Presentation transcript:

PPMI Pathology Core Tatiana Foroud & Tom Montine

Pathology Core Infrastructure Stanford University Pathology Core Indiana University Pathology Core

PPMI Pathology Core Overview Plan Brain Donation Introduction to Participant Brain Collection Neuropath Evaluation Specimen Repository

Site Coordinators are the Key! Provide talking points for site coordinators and stress their important role in helping with engagement Contribution to understanding PD progression No additional cost to subject Post mortem report provided to family

Pathology Core Referral

PPMI Site Referrals to Pathology Core Pending Amend 12 approval: (19) University of South Florida, (28) JHU, (88) NWU

PPMI Subject Referrals by Arm

PPMI Pathology Core Update PPMI Site Referral to PPMI Path Core (n=367) PPMI Path Core: Contacts Subject, explains Core (n= 367) Not yet successfully contacted (n=52) & Request delayed planning (n=16) Decline/lost to f-up (n=54) Subject sent IC and CRF (paper/electronic) (n=245) IC pending completion; reminder sent every 3 weeks (n=110) Completed IC and CRF received (n=135) Still planning (n=8) Brain removal plan in place and documented (n=127)

Planning Challenges Finding removal specialists with 24/7 coverage to help with <8 hr removal goals Coordinating donations for subjects enrolled in multiple donations programs Identifying subjects who might have already donated to other brain banks

Brain Donation Three PPMI subjects have samples at Stanford University One individual was planned by PPMI Pathology Core and brain was successfully obtained Two individuals had planned for donation prior to the establishment of the PPMI Pathology Core Tissue/slides from recipient brain banks transferred to Stanford Preliminary evaluation of one case completed ClinicoPathologic Case (CPC) conference to be scheduled

Goals for the Coming Year Annual confirmation with PPMI participants who have a plan in place Continue to receive referrals from US PPMI sites European and International PPMI site expansion Establish harmonized IHC staining protocol across international sites Neuropathology evaluation to be performed at either international site with data transfer to Stanford or at Stanford Finalize plans for data transfer with LONI Pathology slide images (Stanford University) Pathology specimen catalog (Indiana University)

Case 2018-01 80 yo woman with history of movement disorder and cognitive impairment Brain 1370 gm Mild cerebral cortical atrophy Enlarged lateral ventricles Moderate atrophy of hippocampus Moderate pallor of SN and LC

Anti-Amyloid B (6E10) IHC, Cerebellum

Anti-PHF-tau IHC; BA17

H&E/LFB; Substantia Nigra

Anti-P129 alpha-Synuclein IHC; DMN X

Anti-P129 alpha-Synuclein IHC; BA9

Anti-P129 alpha-Synuclein IHC; amygdala

PPMI Case 2018-01 High Level AD Neuropathologic Change A3, B3, C3 CAA (grade 2/3) Neocortical LB Disease DMNX, SN, anterior cingulate gyrus, BA9 Amygdala No evidence of: Microinfarcts Hippocampal sclerosis TDP-43 cytoplasmic inclusions